The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases-Reference-Cited by-同舟云学术

The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases

Published:2017-11 Issue: Volume:125 Page:21-38
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Li Xiao C.,Zhang Jianfeng,Zhuo Jia L.

Funder

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIDDK/National Institute of General Medical Sciences

National Heart, Lung, And Blood Institute

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology

Reference225 articles.

1. International union of pharmacology. XXIII. The angiotensin II receptors;de Gasparo;Pharmacol. Rev.,2000

2. Under pressure: the search for the essential mechanisms of hypertension;Coffman;Nat. Med.,2011

3. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease;Kobori;Pharmacol. Rev.,2007

4. Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation;Carey;Endocr. Rev.,2003

5. New frontiers in the intrarenal Renin-Angiotensin system: a critical review of classical and new paradigms;Zhuo;Front. Endocrinol. (Lausanne),2013

Cited by 321 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of anaerobic treatment on the non-volatile components and angiotensin-converting enzyme (ACE) inhibitory activity of purple-colored leaf tea;Food Chemistry: X;2024-10

2. Targeting the epidermal growth factor receptor (EGFR/ErbB) for the potential treatment of renal pathologies;Frontiers in Pharmacology;2024-08-21

3. Severe COVID-19 infection: An institutional review and literature overview;PLOS ONE;2024-08-20

4. The prevalence of monotherapy and combination therapy in hypertension in China from 2019 to 2021: A nationwide population‐based cross‐sectional study;The Journal of Clinical Hypertension;2024-07-16

5. The Evaluation of Drugs as Potential Modulators of the Trafficking and Maturation of ACE2, the SARS-CoV-2 Receptor;Biomolecules;2024-06-27